GNMK Insider Trading Activity and SEC Form 4 Filings
GNMK insider trading summary
No open-market insider purchases or sales of GenMark Diagnostics, Inc. (GNMK) have been reported on SEC Form 4 in the past 12 months.
Latest GNMK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 18, 2021 | Tyler Jensen | SVP, Engineering and Tech Dev | Sell | $12K (500 @ $23.88) |
| Mar 5, 2021 | Christine Shaw | VP, Assay Development | Sell | $5K (274 @ $18.56) |
| Mar 4, 2021 | Tyler Jensen | SVP, Engineering and Tech Dev | Sell | $9K (500 @ $18.86) |
| Mar 1, 2021 | Alan Baer Maderazo | VP, Qual, Reg, & Clin Affairs | Sell | $41K (2,127 @ $19.19) |
| Feb 26, 2021 | Michael John Harkins | SVP, Sales | Sell | $211K (12,381 @ $17.03) |
| Feb 26, 2021 | Michael Gleeson | SVP, Corp. Accounts | Sell | $302K (17,750 @ $17.01) |
| Feb 26, 2021 | Christine Shaw | VP, Assay Development | Sell | $54K (3,151 @ $17.03) |
| Feb 26, 2021 | Sarah Hollis Winkler | VP, Human Resources | Sell | $190K (11,181 @ $17.01) |
| Feb 25, 2021 | Alan Baer Maderazo | VP, Qual, Reg, & Clin Affairs | Sell | $5K (266 @ $19.16) |
| Feb 24, 2021 | Alan Baer Maderazo | VP, Qual, Reg, & Clin Affairs | Sell | $3K (163 @ $19.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.